Loading...
XLON
SUN
Market cap7mUSD
Dec 05, Last price  
0.59GBP
1D
2.59%
1Q
-15.73%
Jan 2017
-86.12%
Name

Surgical Innovations Group PLC

Chart & Performance

D1W1MN
XLON:SUN chart
P/E
P/S
0.46
EPS
Div Yield, %
Shrs. gr., 5y
3.38%
Rev. gr., 5y
2.16%
Revenues
12m
-0.57%
4,018,0004,460,0004,770,0004,312,0004,541,0007,045,0007,602,0007,639,0008,553,0004,029,0005,468,0006,089,0008,752,00010,969,00010,733,0006,329,0009,126,00011,340,00012,014,00011,945,000
Net income
-2m
L+281.73%
402,000696,000765,000630,000525,0001,788,0001,738,000686,000800,000-9,457,000-2,033,000716,000626,000725,000-2,619,000-3,276,000-456,000264,000-509,000-1,943,000
CFO
-74k
L
230,000625,000-428,0007,0001,439,0002,202,0001,775,000612,0001,268,000-485,0001,506,0002,845,0001,608,0001,650,000594,0001,042,000-433,000486,000400,000-74,000

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Surgical Innovations Group plc, together with its subsidiaries, designs, develops, manufactures, and sells devices for use in minimally invasive surgery (SI) and precision engineering markets in the United Kingdom, Europe, the Asia Pacific, the United States, and internationally. It operates through three segments: SI Brand, Original Equipment Manufacturer (OEM), and Distribution. The company's SI Brand segment researches, develops, manufactures, and distributes SI branded minimally invasive devices. This segment also offers YelloPort Elite and YelloPort +plus laparoscopic port access systems; LogiRange resposable laparoscopic instrument systems; FastClamp laparoscopic clamping systems; and QuickRange single use laparoscopic instrumentation. Its OEM segment researches, develops, manufactures, and distributes minimally invasive devices for third party medical device companies through own label or co-branding. This segment also provides design and development solutions for producing a final device; and researches, develops, manufactures, and sells minimally invasive technology products for precision engineering applications. The company's Distribution segment distributes medical products through Elemental Healthcare Ltd. It also designs and manufactures autologous blood products. It sells its products through independent healthcare distributors, as well as its own label products through OEM relationships. Surgical Innovations Group plc was incorporated in 1988 and is based in Leeds, the United Kingdom.
IPO date
Jul 07, 1998
Employees
92
Domiciled in
GB
Incorporated in
GB

Valuation

Title
GBP in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT